Novartis Pharmaceuticals Company Profile

Aggregated data from the web about Novartis Pharmaceuticals

Company Name	Novartis Pharmaceuticals
Website	https://www.novartis.com
Snippet	The Novartis Commitment to Patients and Caregivers Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Ukraine response June 01, 2022. Novartis resumes business in Ukraine. Learn More. More statements.
ISIN	CH0012005267
Type	Public (Aktiengesellschaft)
Founded	1996, (from merger)
Revenue	US$48.66 billion (2020)[2]
Website	Novartis.com
Founders	Johann RudolfAlexander Clavel
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Traded as	SIX: NOVN, NYSE: NVS
Key people	Vasant Narasimhan (CEO)[1]
Net income	US$8.07 billion (2020)[2]
Area served	Worldwide
Predecessor	Ciba-Geigy, Sandoz (via merger)
Headquarters	Basel, Switzerland (Global Commercial)
Total assets	US$132.06 billion (2020)[2]
Total equity	US$56.67 billion (2020)[2]
Operating income	US$10.15 billion (2020)[2]
Number of employees	110,000 (2020)[2]

Novartis Pharmaceuticals is part of the Switzerland company list

Novartis Pharmaceuticals is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.